145.27

1.34% -1.97

Merck Co Inc (MRK)

概要ニュース株価時系列オプションチェーン Financials ディスカッション予測株式分割株の配当実績

前日終値:

$147.24

開ける：

$145.02

24時間の取引高:

8.38M

Relative Volume:

0.78

時価総額：

$358.41B

収益：

$65.51B

当期純損益:

$8.93B

株価収益率:

40.88

EPS:

3.5532

ネットキャッシュフロー:

$14.12B

1週間パフォーマンス:

-0.47%

1か月パフォーマンス:

-1.90%

6か月パフォーマンス:

+26.74%

1年パフォーマンス:

+66.63%

1日の値動き範囲:

$143.41

$145.44

1週間の範囲:

$143.41

$154.02

52週間の値動き範囲:

$82.01

$156.92

Merck Co Inc Stock (MRK) Company Profile

名前

Merck Co Inc

セクター

Healthcare (1052)

産業

Drug Manufacturers - General (21)

電話

908-740-4000

住所

126 EAST LINCOLN AVENUE, RAHWAY, NJ

職員

75,000

Twitter

@Merck

次回の収益日

2026-10-29

最新のSEC提出書

MRK's Discussions on Twitter

Compare MRK vs LLY, JNJ, ABBV, NVS

株式	価格	時価総額	収益	当期純利益	現金流量	EPS
MRK Merck Co Inc	145.27	358.41B	65.51B	8.93B	14.12B	3.5532
LLY Lilly Eli Co	1,273.46	1.14T	72.25B	25.28B	10.37B	27.78
JNJ Johnson Johnson	263.81	635.07B	97.93B	21.04B	17.80B	8.6278
ABBV Abbvie Inc	285.64	504.76B	62.82B	3.60B	19.98B	2.0274
NVS Novartis Ag Adr	151.12	287.24B	54.66B	13.58B	16.05B	7.0171

Merck Co Inc Stock (MRK) Upgrades & Downgrades

日付	アクション	アナリスト	評価の変更
2026-08-20	アップグレード	Morgan Stanley	Equal-Weight → Overweight
2026-08-20	ダウングレード	RBC Capital Mkts	Outperform → Sector Perform
2026-08-12	アップグレード	Daiwa Securities	Neutral → Outperform
2026-05-06	再開されました	Citigroup	Neutral
2026-02-25	開始されました	RBC Capital Mkts	Outperform
2026-02-20	開始されました	Barclays	Overweight
2026-02-13	アップグレード	Deutsche Bank	Hold → Buy
2026-01-08	アップグレード	Wolfe Research	Peer Perform → Outperform
2025-12-18	アップグレード	BMO Capital Markets	Market Perform → Outperform
2025-11-24	アップグレード	Wells Fargo	Equal Weight → Overweight
2025-11-13	開始されました	Scotiabank	Sector Outperform
2025-10-13	再開されました	Citigroup	Neutral
2025-09-17	ダウングレード	Berenberg	Buy → Hold
2025-05-14	ダウングレード	Citigroup	Buy → Neutral
2025-04-22	開始されました	Cantor Fitzgerald	Neutral
2025-02-18	ダウングレード	Deutsche Bank	Buy → Hold
2025-02-10	ダウングレード	TD Cowen	Buy → Hold
2025-01-08	ダウングレード	Truist	Buy → Hold
2024-12-20	ダウングレード	BMO Capital Markets	Outperform → Market Perform
2024-12-10	再開されました	BofA Securities	Buy
2024-12-04	アップグレード	HSBC Securities	Hold → Buy
2024-11-15	開始されました	Wolfe Research	Peer Perform
2024-11-11	ダウングレード	Daiwa Securities	Buy → Neutral
2024-10-17	開始されました	Bernstein	Mkt Perform
2024-03-11	ダウングレード	Societe Generale	Hold → Sell
2024-01-04	アップグレード	TD Cowen	Market Perform → Outperform
2023-11-09	開始されました	Deutsche Bank	Buy
2023-10-27	アップグレード	BMO Capital Markets	Market Perform → Outperform
2023-10-20	アップグレード	UBS	Neutral → Buy
2023-07-14	開始されました	HSBC Securities	Hold
2023-04-13	アップグレード	Citigroup	Neutral → Buy
2023-03-28	ダウングレード	Societe Generale	Buy → Hold
2023-03-13	ダウングレード	Wells Fargo	Overweight → Equal Weight
2023-03-06	開始されました	Jefferies	Buy
2023-02-22	アップグレード	Wolfe Research	Peer Perform → Outperform
2023-01-04	アップグレード	BofA Securities	Neutral → Buy
2022-11-18	開始されました	Credit Suisse	Outperform
2022-10-10	アップグレード	Guggenheim	Neutral → Buy
2022-09-14	アップグレード	Berenberg	Hold → Buy
2022-07-06	アップグレード	Daiwa Securities	Neutral → Buy
2022-06-06	再開されました	SVB Leerink	Outperform
2022-04-06	再開されました	Morgan Stanley	Equal-Weight
2021-12-17	開始されました	Goldman	Buy
2021-12-16	開始されました	Daiwa Securities	Neutral
2021-12-13	ダウングレード	UBS	Buy → Neutral
2021-12-09	開始されました	Wells Fargo	Overweight
2021-12-07	ダウングレード	Guggenheim	Buy → Neutral
2021-11-29	ダウングレード	Citigroup	Buy → Neutral
2021-11-19	開始されました	BMO Capital Markets	Market Perform
2021-11-01	アップグレード	Argus	Hold → Buy
2021-09-07	ダウングレード	Morgan Stanley	Overweight → Equal-Weight
2021-07-27	再開されました	Truist	Buy
2021-05-20	ダウングレード	Argus	Buy → Hold
2021-04-07	再開されました	RBC Capital Mkts	Sector Perform
2020-11-10	再開されました	Bernstein	Outperform
2020-09-29	開始されました	Berenberg	Hold
2020-08-03	アップグレード	Goldman	Neutral → Buy
2020-06-12	ダウングレード	Wolfe Research	Outperform → Peer Perform
2020-02-27	開始されました	Barclays	Overweight
2020-01-07	開始されました	RBC Capital Mkts	Sector Perform
2019-10-17	再開されました	BofA/Merrill	Neutral
2019-08-16	開始されました	SVB Leerink	Outperform
2019-07-03	開始されました	Mizuho	Buy
2019-05-28	開始されました	Goldman	Neutral
2019-05-13	アップグレード	Atlantic Equities	Neutral → Overweight
2018-10-16	繰り返されました	Citigroup	Buy
2018-10-09	再開されました	Guggenheim	Buy
2018-04-23	アップグレード	Goldman	Neutral → Buy
2018-04-17	アップグレード	Morgan Stanley	Equal-Weight → Overweight
2018-04-05	アップグレード	Barclays	Equal Weight → Overweight
2018-03-12	アップグレード	Leerink Partners	Mkt Perform → Outperform
2018-02-14	繰り返されました	Leerink Partners	Mkt Perform
2018-02-07	繰り返されました	Morgan Stanley	Equal-Weight
2018-01-16	アップグレード	SunTrust	Hold → Buy

すべてを表示

Merck Co Inc (MRK) 最新ニュース

Oct 23, 2026

Why Healthcare ETFs Are Hovering Around One-Year Highs - Zacks Investment Research

Oct 23, 2026

Oct 22, 2026

Moderna, Merck Shares Fall After Possible Melanoma Data Leak - Bloomberg.com

Oct 22, 2026

Stock Market Today, Oct. 22: Moderna Stock Plummets 18% on Melanoma Vaccine Data Leak Reports - The Motley Fool

Oct 22, 2026

Moderna sheds about $24 billion as cancer vaccine data triggers 'sell-the-news' retreat - Reuters

Oct 22, 2026

Merck & Co Inc Stock (MRK) Moved Down by 3.28% on Oct 22: A Full Analysis - TradingKey

Oct 22, 2026

Summit Expands Ivonescimab Development Into Biliary Tract Cancer - Zacks Investment Research

Oct 22, 2026

Earnings Preview: Merck (MRK) Q3 Earnings Expected to Decline - Zacks Investment Research

Oct 22, 2026

6,761 Merck & Co., Inc. $MRK Shares Sold by Smith Chas P & Associates PA Cpas - MarketBeat

Oct 22, 2026

Merck & Co., Inc. $MRK Stock Sold by Inlet Private Wealth LLC - MarketBeat

Oct 22, 2026

Merck & Co., Inc. $MRK Stock Sold by Crossmark Global Holdings Inc. - MarketBeat

Oct 22, 2026

Merck & Co., Inc. $MRK Shares Purchased by Diversify Advisory Services LLC - MarketBeat

Oct 22, 2026

Merck & Co., Inc. (MRK) Set to Release Earnings on Thursday - MarketBeat

Oct 22, 2026

Merck & Co., Inc. $MRK Stock Holdings Lowered by Cantor Fitzgerald Investment Advisors L.P. - MarketBeat

Oct 22, 2026

27,739 Merck & Co., Inc. $MRK Shares Sold by Axxcess Wealth Management LLC - MarketBeat

Oct 22, 2026

Oct 21, 2026

Global Oral Drugs Market is Predicted to Surpass USD 1 Trillion Mark by 2034 | DelveInsight - GlobeNewswire Inc.

Oct 21, 2026

Not Lilly. Not Johnson & Johnson. This Stock Will Be the Biggest Healthcare Winner of 2026 - The Motley Fool

Oct 21, 2026

Can BMY Navigate Generic Challenges Across Its Key Drug Portfolio? - Zacks Investment Research

Oct 21, 2026

Merck & Co., Inc. (NYSE:MRK) Cut to "Strong Sell" at Zacks Research - MarketBeat

Oct 21, 2026

6,860 Merck & Co., Inc. $MRK Shares Sold by QV Investors Inc. - MarketBeat

Oct 21, 2026

119,254 Merck & Co., Inc. $MRK Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat

Oct 21, 2026

Merck & Co., Inc. $MRK Stock Sold by Nisa Investment Advisors LLC - MarketBeat

Oct 21, 2026

Forget COVID: Moderna Is Turning Into a Cancer Company -- and Wall Street Is Taking Notice - The Motley Fool

Oct 21, 2026

Bank Pictet & Cie Europe AG Sells 42,242 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 21, 2026

Why Are Market Participants Following Merck & Co. (NYSE:MRK)? - Kalkine Media

Oct 21, 2026

Lobbying Update: $2,390,000 of MERCK & CO INC lobbying was just disclosed - Quiver Quantitative

Oct 21, 2026

Oct 20, 2026

Is Merck & Co Inc (MRK) Overvalued After 3.2% Rally? GF Value Sa - GuruFocus

Oct 20, 2026

Surrozen Announces Closing of Second Tranche of March 2025 Private Placement for $95.1 Million - GlobeNewswire Inc.

Oct 20, 2026

Net current asset value per share of Merck & Co., Inc. Shs Thailand Depositary Receipts Repr 1 Sh – SET:MRK03 - TradingView

Oct 20, 2026

Catholic Medical Mission Board and Church of the Brethren to mark partnership with ribbon-cutting - GlobeNewswire Inc.

Oct 20, 2026

Merck & Co., Inc. $MRK Stock: Willis Investment Counsel Cuts Holdings - MarketBeat

Oct 20, 2026

Merck (MRK) Has New Cancer Treatments. Can They Outgrow the Keytruda Patent Cliff? - Yahoo Finance

Oct 20, 2026

Merck Discontinues Bacterial Infection Drug in Europe - Benzinga

Oct 20, 2026

Merck & Co Inc Stock (MRK) Opened Up by 3.79% on Oct 20: What Signal Does It Send? - TradingKey

Oct 20, 2026

GSK's New Drugs and Pipeline Hold the Key to Long-Term Growth - Zacks Investment Research

Oct 20, 2026

Merck (NYSE:MRK) Nears Breakout Setup With Strong Technical Ratings - ChartMill

Oct 20, 2026

64,996 Merck & Co., Inc. $MRK Shares Sold by Sumitomo Mitsui DS Asset Management Company Ltd - MarketBeat

Oct 20, 2026

Oct 19, 2026

Merck’s 2.4% Dividend Yield: A Reliable Income Stream or a Risky Bet on Recovery? - Yahoo Finance

Oct 19, 2026

Merck & Co., Inc. $MRK Position Boosted by Fairvoy Private Wealth LLC - MarketBeat

Oct 19, 2026

Merck (MRK) Stock Dips While Market Gains: Key Facts - Zacks Investment Research

Oct 19, 2026

13,487 Merck & Co., Inc. $MRK Shares Sold by Generali Investments Management Co LLC - MarketBeat

Oct 19, 2026

MERCK & CO INC : HSBC RAISES TARGET PRICE TO $175 FROM $172 - Moomoo

Oct 19, 2026

Oct 18, 2026

Merck & Company, Inc. (MRK) Stock Forecasts - Yahoo Finance

Oct 18, 2026

Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors. - The Motley Fool

Oct 18, 2026

Merck & Co., Inc. $MRK Stock: Birch Hill Investment Advisors LLC Cuts Holdings - MarketBeat

Oct 18, 2026

Merck & Co., Inc. $MRK Stock: 1834 Investment Advisors Co. Decreases Position - MarketBeat

Oct 18, 2026

Oct 17, 2026

Merck & Co., Inc. $MRK Stock: Hengehold Capital Management LLC Reduces Position - MarketBeat

Oct 17, 2026

TD Waterhouse Canada Inc. Purchases 131,302 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 17, 2026

Merck & Co., Inc. $MRK Stock: Cantor Fitzgerald Investment Advisors L.P. Cuts Position - MarketBeat

Oct 17, 2026

Merck & Co., Inc. $MRK Stock: Banque Pictet & Cie SA Cuts Holdings - MarketBeat

Oct 17, 2026

Oct 16, 2026

Bristol-Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool

Oct 16, 2026

Merck Co Inc (MRK) 財務データ

収益

当期純利益

現金流量

EPS

Merck Co Inc (MRK) インサイダートレーディング

インサイダートレーディング	関係	日付	取引	コスト	#株式	値 ($)	#株式総数
CHIRFI GUINDO	Officer	Aug 13 '26	Proposed Sale	135.00	10,000	1,350,000	0
JENNIFER L ZACHARY	Officer	Aug 12 '26	Proposed Sale	133.46	80,315	10,718,495	0
RICHARD ROBERT DELUCA JR	Officer	Aug 12 '26	Proposed Sale	131.63	11,699	1,539,992	0
DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Aug 12 '26	Sale	131.63	11,699	1,539,992	110,167
Zachary Jennifer	EVP, General Counsel	Aug 12 '26	Option Exercise	109.78	54,927	6,029,637	125,824
Zachary Jennifer	EVP, General Counsel	Aug 12 '26	Sale	133.46	80,315	10,718,495	45,509
DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Aug 11 '26	Sale	131.76	12,837	1,691,426	121,866
RICHARD ROBERT DELUCA JR	Officer	Aug 11 '26	Proposed Sale	131.76	12,837	1,691,426	0
DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Aug 10 '26	Sale	130.43	20,784	2,710,951	134,703
RICHARD ROBERT DELUCA JR	Officer	Aug 10 '26	Proposed Sale	130.43	20,784	2,710,951	0

NVS

$151.12

3.30%

AZN

$171.49

0.63%

AMGN

$439.26

1.79%

ABBV

$285.64

0.16%

GILD

$156.04

0.73%

NVO

$39.05

0.96%

Merck Co Inc (MRK)

Merck Co Inc Stock (MRK) Company Profile

Compare MRK vs LLY, JNJ, ABBV, NVS

Merck Co Inc Stock (MRK) Upgrades & Downgrades

Merck Co Inc (MRK) 最新ニュース

Why Healthcare ETFs Are Hovering Around One-Year Highs - Zacks Investment Research

Moderna, Merck Shares Fall After Possible Melanoma Data Leak - Bloomberg.com

Stock Market Today, Oct. 22: Moderna Stock Plummets 18% on Melanoma Vaccine Data Leak Reports - The Motley Fool

Moderna sheds about $24 billion as cancer vaccine data triggers 'sell-the-news' retreat - Reuters

Merck & Co Inc Stock (MRK) Moved Down by 3.28% on Oct 22: A Full Analysis - TradingKey

Summit Expands Ivonescimab Development Into Biliary Tract Cancer - Zacks Investment Research

Earnings Preview: Merck (MRK) Q3 Earnings Expected to Decline - Zacks Investment Research

6,761 Merck & Co., Inc. $MRK Shares Sold by Smith Chas P & Associates PA Cpas - MarketBeat

Merck & Co., Inc. $MRK Stock Sold by Inlet Private Wealth LLC - MarketBeat

Merck & Co., Inc. $MRK Stock Sold by Crossmark Global Holdings Inc. - MarketBeat

Merck & Co., Inc. $MRK Shares Purchased by Diversify Advisory Services LLC - MarketBeat

Merck & Co., Inc. (MRK) Set to Release Earnings on Thursday - MarketBeat

Merck & Co., Inc. $MRK Stock Holdings Lowered by Cantor Fitzgerald Investment Advisors L.P. - MarketBeat

27,739 Merck & Co., Inc. $MRK Shares Sold by Axxcess Wealth Management LLC - MarketBeat

Global Oral Drugs Market is Predicted to Surpass USD 1 Trillion Mark by 2034 | DelveInsight - GlobeNewswire Inc.

Not Lilly. Not Johnson & Johnson. This Stock Will Be the Biggest Healthcare Winner of 2026 - The Motley Fool

Can BMY Navigate Generic Challenges Across Its Key Drug Portfolio? - Zacks Investment Research

Merck & Co., Inc. (NYSE:MRK) Cut to "Strong Sell" at Zacks Research - MarketBeat

6,860 Merck & Co., Inc. $MRK Shares Sold by QV Investors Inc. - MarketBeat

119,254 Merck & Co., Inc. $MRK Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat

Merck & Co., Inc. $MRK Stock Sold by Nisa Investment Advisors LLC - MarketBeat

Forget COVID: Moderna Is Turning Into a Cancer Company -- and Wall Street Is Taking Notice - The Motley Fool

Bank Pictet & Cie Europe AG Sells 42,242 Shares of Merck & Co., Inc. $MRK - MarketBeat

Why Are Market Participants Following Merck & Co. (NYSE:MRK)? - Kalkine Media

Lobbying Update: $2,390,000 of MERCK & CO INC lobbying was just disclosed - Quiver Quantitative

Is Merck & Co Inc (MRK) Overvalued After 3.2% Rally? GF Value Sa - GuruFocus

Surrozen Announces Closing of Second Tranche of March 2025 Private Placement for $95.1 Million - GlobeNewswire Inc.

Net current asset value per share of Merck & Co., Inc. Shs Thailand Depositary Receipts Repr 1 Sh – SET:MRK03 - TradingView

Catholic Medical Mission Board and Church of the Brethren to mark partnership with ribbon-cutting - GlobeNewswire Inc.

Merck & Co., Inc. $MRK Stock: Willis Investment Counsel Cuts Holdings - MarketBeat

Merck (MRK) Has New Cancer Treatments. Can They Outgrow the Keytruda Patent Cliff? - Yahoo Finance

Merck Discontinues Bacterial Infection Drug in Europe - Benzinga

Merck & Co Inc Stock (MRK) Opened Up by 3.79% on Oct 20: What Signal Does It Send? - TradingKey

GSK's New Drugs and Pipeline Hold the Key to Long-Term Growth - Zacks Investment Research

Merck (NYSE:MRK) Nears Breakout Setup With Strong Technical Ratings - ChartMill

64,996 Merck & Co., Inc. $MRK Shares Sold by Sumitomo Mitsui DS Asset Management Company Ltd - MarketBeat

Merck’s 2.4% Dividend Yield: A Reliable Income Stream or a Risky Bet on Recovery? - Yahoo Finance

Merck & Co., Inc. $MRK Position Boosted by Fairvoy Private Wealth LLC - MarketBeat

Merck (MRK) Stock Dips While Market Gains: Key Facts - Zacks Investment Research

13,487 Merck & Co., Inc. $MRK Shares Sold by Generali Investments Management Co LLC - MarketBeat

MERCK & CO INC : HSBC RAISES TARGET PRICE TO $175 FROM $172 - Moomoo

Merck & Company, Inc. (MRK) Stock Forecasts - Yahoo Finance

Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors. - The Motley Fool

Merck & Co., Inc. $MRK Stock: Birch Hill Investment Advisors LLC Cuts Holdings - MarketBeat

Merck & Co., Inc. $MRK Stock: 1834 Investment Advisors Co. Decreases Position - MarketBeat

Merck & Co., Inc. $MRK Stock: Hengehold Capital Management LLC Reduces Position - MarketBeat

TD Waterhouse Canada Inc. Purchases 131,302 Shares of Merck & Co., Inc. $MRK - MarketBeat

Merck & Co., Inc. $MRK Stock: Cantor Fitzgerald Investment Advisors L.P. Cuts Position - MarketBeat

Merck & Co., Inc. $MRK Stock: Banque Pictet & Cie SA Cuts Holdings - MarketBeat

Bristol-Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool

Merck Co Inc (MRK) 財務データ

収益

当期純利益

現金流量

EPS

Merck Co Inc (MRK) インサイダートレーディング

MRKに似た銘柄